🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

KRKA, d.d., Novo mesto — Licensed Medicines

361 medicines held by KRKA, d.d., Novo mesto on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 361 products held by KRKA, d.d., Novo mesto
MedicineActive substanceLicence holderStatus
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 20 mg/5 mg/12.5 mg film-coated tablets
PA1347/096/001
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide KRKA, d.d., Novo mesto Not marketed
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 40 mg/10 mg/12.5 mg film-coated tablets
PA1347/096/004
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide KRKA, d.d., Novo mesto Not marketed
Olmesartan/Amlodipine Krka 20 mg/5 mg film-coated tablets
PA1347/075/001
Olmesartan medoxomil, Amlodipine KRKA, d.d., Novo mesto Marketed
Olmesartan/Amlodipine Krka 40 mg/10 mg film-coated tablets
PA1347/075/003
Olmesartan medoxomil, Amlodipine KRKA, d.d., Novo mesto Marketed
Olmesartan/Amlodipine Krka 40 mg/5 mg film-coated tablets
PA1347/075/002
Olmesartan medoxomil, Amlodipine KRKA, d.d., Novo mesto Marketed
Olmesartan/Hydrochlorothiazide Krka 20 mg/12.5 mg film-coated tablets
PA1347/061/001
Olmesartan medoxomil, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Olmesartan/Hydrochlorothiazide Krka 20 mg/25 mg film-coated tablets
PA1347/061/002
Olmesartan medoxomil, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Olmesartan/Hydrochlorothiazide Krka 40 mg/12.5 mg film-coated tablets
PA1347/061/003
Olmesartan medoxomil, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Olmesartan/Hydrochlorothiazide Krka 40 mg/25 mg film-coated tablets
PA1347/061/004
Olmesartan medoxomil, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Oprymea 0.088 mg tablets
EU/1/08/469/1-5
Pramipexole KRKA, d.d., Novo mesto
Oprymea 0.18 mg tablets
EU/1/08/469/6-10
Pramipexole KRKA, d.d., Novo mesto
Oprymea 0.26 mg prolonged-release tablets
EU/1/08/469/026-029
Pramipexole KRKA, d.d., Novo mesto
Oprymea 0.35 mg tablets
EU/1/08/469/11-15
Pramipexole KRKA, d.d., Novo mesto
Oprymea 0.52 mg prolonged-release tablets
EU/1/08/469/030-033
Pramipexole KRKA, d.d., Novo mesto
Oprymea 0.7 mg tablets
EU/1/08/469/16-20
Pramipexole KRKA, d.d., Novo mesto
Oprymea 1.05 mg prolonged-release tablets
EU/1/08/469/034-037
Pramipexole KRKA, d.d., Novo mesto
Oprymea 1.1 mg tablets
EU/1/08/469/21-25
Pramipexole KRKA, d.d., Novo mesto
Oprymea 1.57 mg prolonged-release tablets
EU/1/08/469/038-041
Pramipexole KRKA, d.d., Novo mesto
Oprymea 2.1 mg prolonged-release tablets
EU/1/08/469/042-045
Pramipexole KRKA, d.d., Novo mesto
Oprymea 2.62 mg prolonged-release tablets
EU/1/08/469/046-049
Pramipexole dihydrochloride monohydrate KRKA, d.d., Novo mesto
Oprymea 3.15 mg prolonged-release tablets
EU/1/08/469/050-053
Pramipexole dihydrochloride monohydrate KRKA, d.d., Novo mesto
Paglitaz
EU/1/11/721/001-007
Pioglitazone hydrochloride KRKA, d.d., Novo mesto
Paglitaz
EU/1/11/721/008-014
Pioglitazone hydrochloride KRKA, d.d., Novo mesto
Paglitaz
EU/1/11/721/015-021
Pioglitazone hydrochloride KRKA, d.d., Novo mesto
Paliperidone Krka 3 mg prolonged-release tablets
PA1347/092/001
Paliperidone KRKA, d.d., Novo mesto Marketed
Paliperidone Krka 6 mg prolonged-release tablets
PA1347/092/002
Paliperidone KRKA, d.d., Novo mesto Marketed
Paliperidone Krka 9 mg prolonged-release tablets
PA1347/092/003
Paliperidone KRKA, d.d., Novo mesto Marketed
Paracetamol Krka 500 mg tablets
PA1347/095/001
Paracetamol KRKA, d.d., Novo mesto Not marketed
Perindopril arginine/Indapamide/Amlodipine Krka 10 mg/2.5 mg/10 mg tablets
PA1347/112/003
Perindopril arginine, Indapamide, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril arginine/Indapamide/Amlodipine Krka 10 mg/2.5 mg/5 mg tablets
PA1347/112/002
Perindopril arginine, Indapamide, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril arginine/Indapamide/Amlodipine Krka 5 mg/1.25 mg/5 mg tablets
PA1347/112/001
Perindopril arginine, Indapamide, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril Krka 2 mg tablets
PA1347/041/001
Perindopril tert-butylamine KRKA, d.d., Novo mesto Marketed
Perindopril Krka 4 mg tablets
PA1347/041/002
Perindopril tert-butylamine KRKA, d.d., Novo mesto Marketed
Perindopril Krka 8 mg tablets
PA1347/041/003
Perindopril tert-butylamine KRKA, d.d., Novo mesto Marketed
Perindopril/amlodipine Krka 4 mg/10 mg tablets
PA1347/084/002
Perindopril tert-butylamine, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril/amlodipine Krka 4 mg/5 mg tablets
PA1347/084/001
Perindopril tert-butylamine, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril/amlodipine Krka 8 mg/10 mg tablets
PA1347/084/004
Perindopril tert-butylamine, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Perindopril/amlodipine Krka 8 mg/5 mg tablets
PA1347/084/003
Perindopril tert-butylamine, Amlodipine besilate KRKA, d.d., Novo mesto Not marketed
Pomalidomide Krka 1 mg hard capsules
EU/1/24/1832/001-002
Pomalidomide Krka, d.d., Novo mesto
Pomalidomide Krka 2 mg hard capsules
EU/1/24/1832/003-004
Pomalidomide Krka, d.d., Novo mesto
Pomalidomide Krka 3 mg hard capsules
EU/1/24/1832/005-006
Pomalidomide Krka, d.d., Novo mesto
Pomalidomide Krka 4 mg hard capsules
EU/1/24/1832/007-008
Pomalidomide Krka, d.d., Novo mesto
Prasugrel Krka 10 mg Film-coated tablets
PA1347/080/002
Prasugrel KRKA, d.d., Novo mesto Not marketed
Prasugrel Krka 5 mg Film-coated tablets
PA1347/080/001
Prasugrel KRKA, d.d., Novo mesto Not marketed
Pregabalin Krka 100 mg hard capsules
PA1347/050/004
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 150 mg hard capsules
PA1347/050/005
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 200 mg hard capsules
PA1347/050/006
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 225 mg hard capsules
PA1347/050/007
Pregabalin KRKA, d.d., Novo mesto Not marketed
Pregabalin Krka 25mg hard capsules
PA1347/050/001
Pregabalin KRKA, d.d., Novo mesto Marketed
Pregabalin Krka 300 mg hard capsules
PA1347/050/008
Pregabalin KRKA, d.d., Novo mesto Marketed
2 3 4 5 6 7 8
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.